RCKTROCKET PHARMACEUTICALS, INC.vs its industry peers
A metric-by-metric comparison of ROCKET PHARMACEUTICALS, INC. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RCKT본 종목 | $270M#1 | — | 0.7x#1 | — | — | 13.8%#3 | — | -60.5%#5 | — | — | -30.9%#2 | — |
| ARCT | $265M#2 | — | 1.5x#2 | 3.2x#2 | -46.1%#4 | 18.7%#2 | -93.0%#3 | -38.3%#2 | -136.2%#3 | — | 0.3%#1 | — |
| QTTB | $262M#3 | 2.8x#1 | 2.5x#5 | 4.9x#3 | — | 162.5%#1 | 31.5%#1 | 28.1%#1 | — | — | — | — |
| LRMR | $261M#4 | — | 2.1x#4 | — | — | -105.5%#7 | — | -130.1%#6 | -350.3%#4 | — | — | — |
| BCYC | — | — | — | — | 105.8%#2 | -29.5%#5 | -340.4%#4 | -43.3%#3 | -372.9%#5 | — | — | — |
| GLSI | $253M#5 | — | 81.0x#6 | — | — | -11.2%#4 | — | -621.1%#7 | — | — | — | — |
| CAMP | $245M#6 | — | — | 70.1x#5 | 436.5%#1 | -55.2%#6 | -1502.4%#5 | — | — | — | — | — |
| ABEO | $244M#7 | — | 1.9x#3 | 42.0x#4 | — | -211.7%#8 | -1536.9%#6 | -55.6%#4 | -121.6%#2 | — | — | — |
| LFCR | $244M#8 | — | — | 1.9x#1 | 0.5%#3 | -422.5%#9 | -13.4%#2 | — | -28.7%#1 | 3#1 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice